European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese(Azienda Ospedaliero-Universitaria Careggi), Laurent Beaugerie(Sorbonne Université), Laurence J. Egan(Ollscoil na Gaillimhe – University of Galway), Livia Biancone(University of Rome Tor Vergata), Claus Bolling(Agaplesion Markus Hospital), Christian Brandts(Goethe University Frankfurt), Daan Dierickx(KU Leuven), Reinhard Dummer(University of Zurich), Gionata Fiorino(IRCCS Humanitas Research Hospital), Jean Marc Gornet(Hôpital Saint-Louis), Peter Higgins(University of Michigan–Ann Arbor), Konstantinos H. Katsanos(University of Ioannina), Loes H.C. Nissen(Radboud University Nijmegen), Gianluca Pellino(University of Campania "Luigi Vanvitelli"), Gerhard Rogler, Franco Scaldaferri(Università Cattolica del Sacro Cuore), Edyta Szymańska(Children's Memorial Health Institute), Rami Eliakim(Sheba Medical Center), on behalf of ECCO
Cited by 420Open Access
Abstract
than non-IBD CRC patients, but they survived about 3 years longer. Older age, male sex, smoking, and advanced CRC grade and stage were independently associated with shorter survival times. When propensity score matching was used to analyse outcomes, the survival times of CRC patients with and without IBD were not significantly different. Taken together, these results reveal that IBD patients tend to develop CRC at younger ages than non-IBD patients. However, no effect of IBD on patient survival has been consistently demonstrated.
Related Papers
No related papers found
Powered by citation graph analysis